Theoretically, increased serum IgA responses might blunt the protective action of non-neutralizing antibodies because the IgA Fc region does not mediate the same effector functions, which might explain why serum IgA levels positively correlated with HIV-1 infection risk in RV144 vaccinees 4. The gene discussed is CD79A; the disease is HIV-1 infection.